奶油
法尼甾体X受体
普吕卡贡
分泌物
细胞生物学
内分泌学
内科学
生物
肠内分泌细胞
信号转导
前蛋白转化酶
胰高血糖素样肽-1
化学
核受体
转录因子
激素
生物化学
2型糖尿病
糖尿病
低密度脂蛋白受体
基因
医学
内分泌系统
胆固醇
脂蛋白
作者
Pengzhou Li,Liyong Zhu,Xiangwu Yang,Weizheng Li,Xulong Sun,Bo Yi,Shaihong Zhu
摘要
Abstract Type II diabetes is a complex, chronic, and progressive disease. Glucagon‐like peptide‐1 (7–36) amide (GLP‐1) is a gut hormone released from the L cells which stimulate insulin secretion and promotes insulin gene expression and β‐cell growth and differentiation. Elevated levels of hormones secreted by L cells are an essential reason for diabetes improvement. GLP‐1 secretion has been reported to be regulated by farnesoid X receptor (FXR), a transcriptional sensor for bile acids which also acts on glucose metabolism. Herein, we attempted to evaluate the effect of FXR on GLP‐1 secretion in mouse enteroendocrine L cell line, namely STC‐1, and to investigate the underlying mechanism. FXR inversely regulated GLP‐1 secretion in STC‐1. A total of 24 nonredundant human proteins were shown to be related to FXR by BioGRID; KEGG pathway analysis revealed that FXR was related to glucagon signaling pathway, particularly with the transcriptional activators CREB, PGC1α, Sirt1, and CBP. CREB could positively regulate GLP‐1 secretion in STC‐1 cells. FXR combined with CREB to inhibit its transcriptional activity, thus inhibiting proprotein convertase subtilisin/kexin type 1 protein level and GLP‐1 secretion. In the present study, we demonstrated a negative regulation of GLP‐1 secretion by FXR in L cell line, STC‐1; FXR exerts its function in L cells through interacting with CREB, a crucial transcriptional regulator of cAMP–CREB signaling pathway, to inhibit its transcriptional activity. Targeting FXR to rescue GLP‐1 secretion may be a promising strategy for type II diabetes.
科研通智能强力驱动
Strongly Powered by AbleSci AI